Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 30, 2026

Back to today

TSOH Weekly Roundup (10/30/2026)

Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.

BBW $327M
TSOH Investment Research 1 click

From X

@pennycheck 1 click

⚽️📡 on X

$BFLY earnings thoughts Overall very pleased. Numbers were excellent double beat and raise with record gross margins --- This despite weakness in int'l sales due to lumpiness and weakness from sales team but happy to hear on the call they are very aggressively working to switch their int'l sales model to the us based one which focuses mainly on large enterprise deals . The fact they had such strong numbers despite int'l weakness is promising. embedded rev which is the real growth driver is ramping - went from practically zero to over 11 million but they didnt disclose exact contribution to that was from mid journey 15 new contracts in the last Q for compass AI ten 7 figure deals five 6 figure deals ! also most noteable for the data moat compass in getting up to 80% of all scans in some hospitals vastly improving the ai data moat All the near term catalysts are on track home + CC rev is already starting in Q4 w/partners already wanting to expand to bladder and spesis scans. P5.1 next gen chip/probe on track to start shipping early 27 as well expanding into icu and cardiology verticals highlighted near term opportunities non medical / wearables already shipping to embedded partners some really interesting commentary on fed ramp approval and some very large potential opportunities. most interesting thing for me personally on the call was they referenced around 7 times that the next big "mid-journey" type of deal was coming soon. thesis fully intact on this one of one. $SILC earnings thoughts Overall solid but disappointed by lack of color on the cyber security refresh cycle. Solid EPS beat slight revenue beat + raise return to profitability earlier than forecasted and mentioned on call expect that to accelerate in Q4 seems like a interesting upcoming catalyst "in final discussions with a new customer on a “major evolving use case” and expect agreement imminently" design wins ahead of schedule although bearish flag that one inference partner left due to a change in strategy which i think is main cause for weakness today but if this next deal is as imminent as they imply investor confidence should return. other bearish flag is inventory remains quite elevated at 73M but they did mention on call they expect refreshes coming soon from core cyber security biz unfortunate that there was only one analyst in the q + a so didn't get a ton of color i really would of loved to know more about this cyber security refresh and it was only adressed in passing due to the analyst question but in general with near term catalyst as well as continued healthy rev growth and return to non-gaap profitability stock feels cheap here
@StableBread

Fajasy on X

First Solar $FSLR trades at 6.7x TTM EBITDA and 10.4x TTM net income, while TOYO Co., Ltd $TOYO trades at just 0.9x and 2.0x. At $3.83/share, $TOYO has a market cap of $163.6M and an EV of $137.2M ($163.6M + $25.7M of bank loans + $51.4M owed to VSUN, an affiliate - $103.5M of cash). It trades at 0.9x TTM EBITDA of $156.4M, 2.0x TTM net income of $80.5M, and 0.78x its $209.8M of book value. Since 80.7% of its H1 revenue came from U.S. end customers, $TOYO’s closest comps are four other listed solar manufacturers selling into the U.S. (TTM multiples as of the October 26 close): → First Solar $FSLR (U.S. thin-film panel maker): 6.7x EV/EBITDA, 10.4x P/E, 1.75x P/B, and down 47.2% from its 2026 high. → Canadian Solar $CSIQ (panel and battery storage maker): 18.8x EV/EBITDA, a net loss, 0.22x P/B, and down 65.2%. → JinkoSolar $JKS (China-based panel maker): A net loss, 0.19x P/B, and down 72.7%. → T1 Energy $TE (Texas panel assembler building a U.S. cell plant): Negative EBITDA, a net loss, 2.95x P/B, and down 82.4%. So the market prices $TOYO’s earnings at 0.9x EBITDA, less than a seventh of First Solar’s 6.7x, a multiple that only makes sense if the four U.S. trade actions on its Ethiopian cells wipe out most of those earnings. Only $TE has fallen further from its 2026 high. I was originally going to write up T1 Energy until I found $TOYO, which offers a more attractive setup mainly because (1) it’s profitable, with $80.5M of TTM net income vs. T1’s $367.8M net loss, (2) it trades at 0.78x book vs. T1’s 2.95x, and (3) it has $26.4M of net cash vs. T1’s $629.2M of net debt.
@leevalueroach

Lee Roach on X

Monroe $MNRO is selling off on a weak Q2, down around 9% premarket. I think most of the market is reading the headline and missing what's buried in the new credit agreement. The Oct 23 refinancing with Ares ($250M term loan + $125M revolver, EX-10.23) runs well over 100 pages. Deep in the definitions is a "Permitted Change of Control" clause, and it's very specific: - One sale to a private-equity sponsor can happen without triggering a default - It must happen by Oct 23, 2027, a 12-month window - The sponsor needs $1.5B+ AUM, can't be on a disqualified-firm list that Ares and Monro pre-agreed, and must be in an approved jurisdiction - Pro forma lease-adjusted leverage must be 5.50x or less - Sponsor equity must be at least equal to all funded debt, including finance leases - Lenders get a 0.50% fee, and the sponsor can add back up to $2M/yr of management fees Lenders don't negotiate a provision this detailed (a named AUM floor, a pre-agreed blacklist, a fixed window) for a scenario nobody is considering. Meanwhile the board's strategic review, which includes a possible sale, has been open since May. None of this means a deal is coming. No transaction has been announced, and the same agreement also restricts the dividend and adds real interest cost. But headline-driven selling is pricing Monro as a standalone story. The credit agreement says the lenders are planning for a sale to PE and that deal is close.

Investor Letters

All letters

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $104M
Triple S Special Situations Investing 4 clicks
SAMG · long

Silvercrest Asset Mgt

Silvercrest Asset Management is framed as undervalued while funding an ambitious investment cycle.

SAMG $82M
Value Investors Club
BMBL 2026-10-21

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

BMBL $788M
Modern Value Investing 8 clicks

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $274M
Guardian Research 4 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $75M
Calvin Blissett 11 clicks

LXS.DE: a 2028 sale it can force

Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.

LPTH $578M
Trade Ideas Flow 21 clicks

Build-A-Bear: A Narrower Path

Build-A-Bear's push into prestuffed toys and broader retail distribution tests brand stretchability, but recent results warrant caution.

BBW $327M
TSOH Investment Research 18 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 266

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.